Cancer Immunotherapy//CAR T Cells

Stroke of Genius

Content provided by IPO Education Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IPO Education Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

5+ y ago 33:10

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on August 01, 2022 20:16 (1+ y ago). Last successful fetch was on February 23, 2022 13:53 (2y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

What if scientists could harness the power of a patient’s own immune system to fight cancer? This episode explores CAR T Cell therapy, a groundbreaking approach to cancer treatment that re-engineers immune cells to recognize and combat cancer cells. We’ll speak with: Dr. Carl June, a pioneer in the field who developed the treatment in his lab at UPenn, Dr. Stephan Grupp, who put the research into practice at the Children’s Hospital of Philadelphia, and meet Tom Whitehead, whose daughter Emily was the very first pediatric patient to receive this treatment.

Learn more:

The Children’s Hospital of Philadelphia’s Cancer Immunotherapy Program

The Emily Whitehead Foundation

See the tocilizumab patent described in this episode

Brought to you by IPO Education Foundation and produced by At Will Media

See acast.com/privacy for privacy and opt-out information.

40 episodes

#IPO Education Foundation #Podcasting Education